Discover the complete record of transactions filed by Fratamico Arthur, Director. Insider active across 1 companies, notably Panbela Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 25 May 2021 — Attribution. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Arthur Fratamico is a Director at Panbela Therapeutics, Inc. He plays a vital role in the governance of the company, bringing his expertise in biotechnology and pharmaceutical development. As a board member, Arthur participates in strategic decision-making that influences the company's performance and direction. His experience in the sector enables him to contribute to discussions on innovation and the development of new treatments, thereby strengthening the company's market position.